Connection

Susan Dorman to Middle Aged

Back to Details
This is a "connection" page, showing publications Susan Dorman has written about Middle Aged.
Susan Dorman
Connection Strength
0.746
Middle Aged
  1. High-dose rifapentine with or without moxifloxacin for shortening treatment of pulmonary tuberculosis: Study protocol for TBTC study 31/ACTG A5349 phase 3 clinical trial. Contemp Clin Trials. 2020 03; 90:105938.
    View in: PubMed
    Score: 0.050
  2. Transmission of Mycobacterium tuberculosis From Patients Who Are Nucleic Acid Amplification Test Negative. Clin Infect Dis. 2018 11 13; 67(11):1653-1659.
    View in: PubMed
    Score: 0.046
  3. Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study. Lancet Infect Dis. 2018 01; 18(1):76-84.
    View in: PubMed
    Score: 0.043
  4. A Phase 2 Randomized Trial of a Rifapentine plus Moxifloxacin-Based Regimen for Treatment of Pulmonary Tuberculosis. PLoS One. 2016; 11(5):e0154778.
    View in: PubMed
    Score: 0.038
  5. Analytical and Clinical Evaluation of the Epistem Genedrive Assay for Detection of Mycobacterium tuberculosis. J Clin Microbiol. 2016 Apr; 54(4):1051-7.
    View in: PubMed
    Score: 0.038
  6. Daily rifapentine for treatment of pulmonary tuberculosis. A randomized, dose-ranging trial. Am J Respir Crit Care Med. 2015 Feb 01; 191(3):333-43.
    View in: PubMed
    Score: 0.035
  7. Diagnostic accuracy of a rapid urine lipoarabinomannan test for tuberculosis in HIV-infected adults. J Acquir Immune Defic Syndr. 2014 Jul 01; 66(3):270-9.
    View in: PubMed
    Score: 0.034
  8. Prospective cross-sectional evaluation of the small membrane filtration method for diagnosis of pulmonary tuberculosis. J Clin Microbiol. 2014 Jul; 52(7):2513-20.
    View in: PubMed
    Score: 0.033
  9. Interferon-? release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States. Am J Respir Crit Care Med. 2014 Jan 01; 189(1):77-87.
    View in: PubMed
    Score: 0.033
  10. Cost-effectiveness of novel algorithms for rapid diagnosis of tuberculosis in HIV-infected individuals in Uganda. AIDS. 2013 Nov 28; 27(18):2883-92.
    View in: PubMed
    Score: 0.032
  11. Substitution of rifapentine for rifampin during intensive phase treatment of pulmonary tuberculosis: study 29 of the tuberculosis trials consortium. J Infect Dis. 2012 Oct 01; 206(7):1030-40.
    View in: PubMed
    Score: 0.030
  12. Safety and pharmacokinetics of escalating daily doses of the antituberculosis drug rifapentine in healthy volunteers. Clin Pharmacol Ther. 2012 May; 91(5):881-8.
    View in: PubMed
    Score: 0.029
  13. Genotype MTBDRplus for direct detection of Mycobacterium tuberculosis and drug resistance in strains from gold miners in South Africa. J Clin Microbiol. 2012 Apr; 50(4):1189-94.
    View in: PubMed
    Score: 0.028
  14. Repeated administration of high-dose intermittent rifapentine reduces rifapentine and moxifloxacin plasma concentrations. Antimicrob Agents Chemother. 2008 Nov; 52(11):4037-42.
    View in: PubMed
    Score: 0.023
  15. Use of the amplified mycobacterium tuberculosis direct test in a public health laboratory: test performance and impact on clinical care. Chest. 2007 Sep; 132(3):946-51.
    View in: PubMed
    Score: 0.021
  16. Clinical evaluation of the microscopic-observation drug-susceptibility assay for detection of tuberculosis. Clin Infect Dis. 2007 Mar 01; 44(5):674-80.
    View in: PubMed
    Score: 0.020
  17. The potential impact of enhanced diagnostic techniques for tuberculosis driven by HIV: a mathematical model. AIDS. 2006 Mar 21; 20(5):751-62.
    View in: PubMed
    Score: 0.019
  18. Immunoglobulin A (IgA) and IgG immune responses against P-90 antigen for diagnosis of pulmonary tuberculosis and screening for Mycobacterium tuberculosis infection. Clin Diagn Lab Immunol. 2004 Jan; 11(1):94-7.
    View in: PubMed
    Score: 0.016
  19. Field evaluation of a rapid immunochromatographic test for tuberculosis. J Clin Microbiol. 2002 Jun; 40(6):1989-93.
    View in: PubMed
    Score: 0.015
  20. Rifapentine Population Pharmacokinetics and Dosing Recommendations for Latent Tuberculosis Infection. Am J Respir Crit Care Med. 2020 09 15; 202(6):866-877.
    View in: PubMed
    Score: 0.013
  21. Predictive value of TNF-a, IFN-?, and IL-10 for tuberculosis among recently exposed contacts in the United States and Canada. BMC Infect Dis. 2020 Jul 31; 20(1):553.
    View in: PubMed
    Score: 0.013
  22. A Population Pharmacokinetic Analysis Shows that Arylacetamide Deacetylase (AADAC) Gene Polymorphism and HIV Infection Affect the Exposure of Rifapentine. Antimicrob Agents Chemother. 2019 04; 63(4).
    View in: PubMed
    Score: 0.012
  23. Performance of the TB-LAMP diagnostic assay in reference laboratories: Results from a multicentre study. Int J Infect Dis. 2018 Mar; 68:44-49.
    View in: PubMed
    Score: 0.011
  24. Evaluation of a Rapid Molecular Drug-Susceptibility Test for Tuberculosis. N Engl J Med. 2017 09 14; 377(11):1043-1054.
    View in: PubMed
    Score: 0.011
  25. Comparing TSPOT assay results between an Elispot reader and manual counts. Tuberculosis (Edinb). 2016 12; 101S:S92-S98.
    View in: PubMed
    Score: 0.010
  26. Differential positive TSPOT assay responses to ESAT-6 and CFP-10 in health care workers. Tuberculosis (Edinb). 2016 12; 101S:S83-S91.
    View in: PubMed
    Score: 0.010
  27. Occupational Risk Factors for Tuberculosis Among Healthcare Workers in KwaZulu-Natal, South Africa. Clin Infect Dis. 2016 05 15; 62 Suppl 3:S255-61.
    View in: PubMed
    Score: 0.010
  28. Novel dosing strategies increase exposures of the potent antituberculosis drug rifapentine but are poorly tolerated in healthy volunteers. Antimicrob Agents Chemother. 2015; 59(6):3399-405.
    View in: PubMed
    Score: 0.009
  29. Improving the sensitivity of the Xpert MTB/RIF assay on sputum pellets by decreasing the amount of added sample reagent: a laboratory and clinical evaluation. J Clin Microbiol. 2015 Apr; 53(4):1258-63.
    View in: PubMed
    Score: 0.009
  30. Population pharmacokinetics of rifapentine and desacetyl rifapentine in healthy volunteers: nonlinearities in clearance and bioavailability. Antimicrob Agents Chemother. 2014 Jun; 58(6):3035-42.
    View in: PubMed
    Score: 0.008
  31. Cost-effectiveness of routine diagnostic evaluation of pulmonary tuberculosis in a primary care unit in Brazil. Int J Tuberc Lung Dis. 2013 Oct; 17(10):1336-40.
    View in: PubMed
    Score: 0.008
  32. The health-system benefits and cost-effectiveness of using Mycobacterium tuberculosis direct nucleic acid amplification testing to diagnose tuberculosis disease in the United States. Clin Infect Dis. 2013 Aug; 57(4):532-42.
    View in: PubMed
    Score: 0.008
  33. The impact of expanded testing for multidrug resistant tuberculosis using genotype [correction of geontype] MTBDRplus in South Africa: an observational cohort study. PLoS One. 2012; 7(11):e49898.
    View in: PubMed
    Score: 0.008
  34. A national infection control evaluation of drug-resistant tuberculosis hospitals in South Africa. Int J Tuberc Lung Dis. 2012 Jan; 16(1):82-9.
    View in: PubMed
    Score: 0.007
  35. Diagnostic accuracy of a urine lipoarabinomannan test for tuberculosis in hospitalized patients in a High HIV prevalence setting. J Acquir Immune Defic Syndr. 2009 Oct 01; 52(2):145-51.
    View in: PubMed
    Score: 0.006
  36. Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis. Am J Trop Med Hyg. 2009 Apr; 80(4):634-9.
    View in: PubMed
    Score: 0.006
  37. Fluoroquinolone resistance in patients with newly diagnosed tuberculosis. Clin Infect Dis. 2003 Dec 01; 37(11):1448-52.
    View in: PubMed
    Score: 0.004
  38. Nocardia veterana as a pathogen in North American patients. J Clin Microbiol. 2003 Jun; 41(6):2560-8.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.